McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q1 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −397−100.0% | Sold out | Holders |
| Q3 2024 | 397 | $184.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 397 | $186.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 397 | $165.9K | <0.1% | +91+29.7% | Added | Holders |
| Q4 2023 | 306 | $124.5K | <0.1% | −91−22.9% | Reduced | Holders |
| Q3 2023 | 397 | $138.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 397 | $139.7K | <0.1% | −9−2.2% | Reduced | Holders |
| Q1 2023 | 406 | $127.9K | <0.1% | +9+2.3% | Added | Holders |
| Q4 2022 | 397 | $114.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 397 | $115.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 397 | $112.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 397 | $104.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 397 | $87.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 397 | $72.0K | <0.1% | −215−35.1% | Reduced | Holders |
| Q2 2021 | 612 | $123.0K | <0.1% | +299+95.5% | Added | Holders |
| Q1 2021 | 313 | $67.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.